共 204 条
[21]
Obach R. S.(2002) activities of cDNA-expressed human cytochromes P-450 J. Biomol. Screen 7 373-382
[22]
Weaver R.(2000)Effect of commonly used organic solvents on the kinetics of cytochrome P450 2B6- and 2C8-dependent activity in human liver microsomes Drug Metab. Dispos 28 125-130
[23]
Graham K. S.(2002)The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties Xenobiotica 32 863-878
[24]
Beattie I. G.(2005)Binding of drugs to hepatic microsomes: Comment and assessment of current prediction methodology with recommendation for improvement (1) Clin. Pharmacokinet 44 279-304
[25]
Riley R. J.(2007)Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC-MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC-MS Current Drug Metabolism 8 407-447
[26]
Dierks E. A.(2003)Optimizing higher throughput methods to assess drug–drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 Arch. Biochem. Biophys 409 59-71
[27]
Stams K. R.(2007) using a single point IC(50) Drug Metab. Dispos 35 246-255
[28]
Lim H. K.(2007)Drug interactions with calcium channel blockers: Possible involvement of metabolite-intermediate complexation with CYP3A Drug Metab. Dispos 35 2159-2165
[29]
Cornelius G.(2006)Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolites Current Drug Metabolism 7 315-334
[30]
Zhang H.(2005)Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs Drug Metab. Dispos 33 413-418